Telix PharmaceuticalsTLPPF -0.40%66 Days Payable is 65.54 as of Dec. 2025, which is 35% below its 10-year median of 100.52. GuruFocus rates TLPPF with a GF Score™ of 66/100 and a GF Value™ of $27.87 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 707 Biotechnology companies, Telix Pharmaceuticals ranks worse than 62.66% on this metric.
Telix Pharmaceuticals Days Payable Historical Data
* Premium members only.
The historical data trend for Telix Pharmaceuticals's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TLPPF vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, Telix Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Telix Pharmaceuticals Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Telix Pharmaceuticals's Days Payable distribution charts can be found below:
* The bar in red indicates where Telix Pharmaceuticals's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Telix Pharmaceuticals's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Telix Pharmaceuticals (TLPPF) has a Days Payable of 65.54 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Telix Pharmaceuticals and its competitors. This is 35% below median its historical median of 100.52. Over the past decade, Telix Pharmaceuticals' Days Payable has ranged from 33.53 to 1,270.50. According to the industry distribution chart, Telix Pharmaceuticals ranks #443 out of 707 companies in the Biotechnology industry, placing it in the top 62.7%.
Is Telix Pharmaceuticals' Days Payable too high?
Telix Pharmaceuticals' current Days Payable of 65.54 is 35% below median its 10-year median of 100.52. Over the past 10 years, this metric has ranged from a low of 33.53 to a high of 1,270.50. The Biotechnology industry median Days Payable is 113.76. Telix Pharmaceuticals' value of 65.54 is 42.4% below this industry median. Based on the distribution chart, Telix Pharmaceuticals ranks #443 out of 707 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Telix Pharmaceuticals has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Telix Pharmaceuticals' Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Telix Pharmaceuticals ranks #443 out of 707 companies for Days Payable. This places Telix Pharmaceuticals in the lower half of its industry. The industry median Days Payable is 113.76. Telix Pharmaceuticals' value of 65.54 is 42.4% below this benchmark. Historically, Telix Pharmaceuticals' own Days Payable has ranged from 33.53 to 1,270.50 over the past decade. While the company's 10-year median is 100.52 vs. the industry median of 113.76, Telix Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.76, based on 707 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Telix Pharmaceuticals's current Days Payable of 65.54 is 42.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Telix Pharmaceuticals and its competitors. For the Biotechnology industry, the median Days Payable is 113.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Telix Pharmaceuticals's current Days Payable is 65.54, which is 35% below median its own 10-year median of 100.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Telix Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Telix Pharmaceuticals (TLPPF) is currently considered Possible Value Trap. The stock's GF Value™ is $27.87, compared to a current price of $10.00 — trading 64.1% below its estimated fair value. The current Days Payable is 65.54, which is 35% below median its 10-year median of 100.52 and 42.4% below the Biotechnology industry median of 113.76. Telix Pharmaceuticals' overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Telix Pharmaceuticals (TLPPF), the current Days Payable is 65.54 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Telix Pharmaceuticals (TLPPF) Overvalued in 2026?
Based on GuruFocus' analysis, Telix Pharmaceuticals stock appears to be undervalued.
The current stock price of $10.00 is trading 64.1% below its estimated GF Value™ of $27.87.
GuruFocus considers Telix Pharmaceuticals to be Possible Value Trap.
Key valuation signals for TLPPF:
Days Payable: 65.54 (35% below median its 10-year median of 100.52)
GF Value™: $27.87 vs. price of $10.00 (64.1% below fair value)
Industry Position: 42.4% below the Biotechnology median (#443 of 707)
No single metric tells the full story. See the TLPPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.
66GF Score
Get the complete analysis for TLPPF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TLPPF has been successfully added to your 
